Literature DB >> 25041426

Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.

N Mahalakshmi1, R Aparnaa, P Kaliraj.   

Abstract

Filariasis caused by infectious parasitic nematodes has been identified as the second leading source of permanent and long-term disability in Sub-Saharan Africa, Asia and Latin America. Several vaccine candidates were identified from infective third-stage larvae (L3) which involves in the critical transition from arthropod to human. Hitherto studies of these antigens in combination with alum adjuvant have shown to elicit its characteristic Th2 responses. Inulin is a safe, non-toxic adjuvant that principally stimulates the innate immune response through the alternative complement pathway. In the present study, the immune response elicited by inulin and alum as adjuvants were compared with filarial antigens from different aetiological agents: secreted larval acidic protein 1 (SLAP1) from Onchocerca volvulus and venom allergen homologue (VAH) from Brugia malayi as single or as cocktail vaccines in mice model. The study revealed that inulin can induce better humoral response against these antigens than alum adjuvant. Antibody isotyping disclosed inulin's ability to elevate the levels of IgG2a and IgG3 antibodies which mediates in complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), respectively, in mice. Splenocyte analysis showed that T cells prestimulated with inulin have higher stimulation index (P < 0.05) than alum except for BmVAH antigen. In vitro ADCC assay showed that inulin formulation had induced higher cytotoxicity with filarial antigens (as single P < 0.01 and as cocktail P < 0.05, respectively) than alum. The results had confirmed the capability of inulin to deplete the levels of Treg and brought a balance in Th1/Th2 arms against filarial antigens in mice.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25041426     DOI: 10.1111/sji.12208

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Immunological evaluation of fusion protein of Brugia malayi abundant larval protein transcript-2 (BmALT-2) and Tuftsin in experimental mice model.

Authors:  Rajkumar Paul; Meganathan Ilamaran; Vishal Khatri; Nitin Amdare; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Parasite Epidemiol Control       Date:  2019-02-07

2.  Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice.

Authors:  Nathan M Ryan; Jessica A Hess; Fernando Pardo-Manuel de Villena; Benjamin E Leiby; Ayako Shimada; Lei Yu; Amir Yarmahmoodi; Nikolai Petrovsky; Bin Zhan; Maria Elena Bottazzi; Benjamin L Makepeace; Sara Lustigman; David Abraham
Journal:  NPJ Vaccines       Date:  2021-01-26       Impact factor: 7.344

Review 3.  Targeting Antigens for Universal Influenza Vaccine Development.

Authors:  Quyen-Thi Nguyen; Young-Ki Choi
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

4.  The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Authors:  Jessica A Hess; Bin Zhan; April R Torigian; John B Patton; Nikolai Petrovsky; Tingting Zhan; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2016-07-07

5.  Elucidation of immunological response and its regulatory network by P-TUFT-ALT-2: a promising fusion protein vaccine for human lymphatic filariasis.

Authors:  Rajkumar Paul; Sandeep Jaiswal; Natarajan Mahalakshmi; Perumal Kaliraj
Journal:  R Soc Open Sci       Date:  2018-05-16       Impact factor: 2.963

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.